Lobbying reported · The United States Pharmacopeial Convention · Jul 20The United States Pharmacopeial Convention reported 1st Quarter (Jan 1 - Mar 31) lobbying for The United States Pharmacopeial Convention — $130,000BillsH.R. 4191S. 1784S. 3788
Lobbying reported · The United States Pharmacopeial Convention · Jul 20The United States Pharmacopeial Convention reported 2nd Quarter (Apr 1 - June 30) lobbying for The United States Pharmacopeial Convention — $120,000BillsH.R. 4191H.R. 4779H.R. 5304H.R. 8800S. 1784S. 2296S. 2587S. 3788
Lobbying reported · Vizient · Jul 20Vizient reported 2nd Quarter (Apr 1 - June 30) lobbying for Vizient — $320,000BillsH.R. 2213H.R. 3178H.R. 3514H.R. 3890H.R. 4191H.R. 4731H.R. 8339S. 1784S. 1816S. 1954S. 2556
Lobbying reported · Phlow · Jul 20Phlow reported 2nd Quarter (Apr 1 - June 30) lobbying for Phlow — $370,000BillsH.R. 4191H.R. 9260H.R. 9495S. 1784
Lobbying reported · Tiber Creek Group · Jul 18Tiber Creek Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Phlow — $90,000BillsH.R. 4191H.R. 8800S. 1784S. 4784
Lobbying reported · Association for Clinical Oncology (ASCO) · Jul 16Association for Clinical Oncology (ASCO) reported 2nd Quarter (Apr 1 - June 30) lobbying for Association for Clinical Oncology (ASCO) — $480,000BillsH.R. 2120H.R. 2433H.R. 2484H.R. 3514H.R. 3521H.R. 4101H.R. 4191H.R. 4206H.R. 4299H.R. 4425H.R. 4559H.R. 4752H.R. 5081H.R. 5509H.R. 5526H.R. 6160H.R. 6423H.R. 8163H.R. 8339H.R. 8622H.R. 8839S. 526S. 864S. 1031S. 1261S. 1460S. 1784S. 1816S. 1954S. 2287S. 2709S. 2903S. 4440